# US 2009/0270944 A1 · Methods and systems for treating a psychotic disorder

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2009/0270944 A1
- Document ID: US20090270944A1
- Status: Published application
- Kind: A1
- Application number: 12/497,386
- Filed: 2009-07-02
- Published: 2009-10-29
- Earliest claimed: 2004-12-22
- Assignees: Boston Scientific Neuromodulation Corporation
- Inventors: Todd K. Whitehurst; Kristen N. Jaax
- Web page: https://patentgrep.com/patent/US20090270944A1

## CPC

- A61N 1/0531: {Brain cortex electrodes}
- A61N 1/0534: {Electrodes for deep brain stimulation}
- A61N 1/36082: {Cognitive or psychiatric applications, e.g. dementia or Alzheimer's disease}
- A61N 1/37205: {Microstimulators, e.g. implantable through a cannula}
- A61N 1/3756: {Casings with electrodes thereon, e.g. leadless stimulators}
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)

## Abstract

Methods of treating a psychotic disorder include applying at least one stimulus to a stimulation site within a patient with an implanted stimulator in accordance with one or more stimulation parameters configured to treat the psychotic disorder. Systems for treating a psychotic disorder include a stimulator configured to apply at least one stimulus to a stimulation site within a patient in accordance with one or more stimulation parameters configured to treat the psychotic disorder.

## Claims

### Claim at position 1

1-20. (canceled)

### Claim 21

A method of treating a psychotic disorder, said method comprising:
applying at least one stimulus to a stimulation site within a patient with an implanted stimulator in accordance with one or more stimulation parameters to treat said psychotic disorder; and
sensing at least one indicator related to said psychotic disorder and using said at least one sensed indicator to adjust one or more of said stimulation parameters;
wherein said stimulation site comprises at least one or more of a frontal lobe, temporal lobe, cingulate gyrus, substantia nigra, thalamus, amygdala, hippocampus, ventral tegmental area, and nucleus accumbens, and locus coeruleus; and
wherein said at least one indicator comprises at least one of a discharge frequency of a neural population in said stimulation site, a chemical level of said stimulation site, a neurotransmitter level, a hormone level, a drug level within said patient, a change in blood plasma, a change in interstitial fluid, a change in cerebrospinal fluid, a dopamine level, an interleukin level, a cytokine level, a lymphokine level, a chemokine level, a growth factor level, an electrolyte level, and an enzyme level.

### Claim 22 (depends on 1)

The method of claim 1, wherein said psychotic disorder comprises schizophrenia.

### Claim 23 (depends on 1)

The method of claim 1, wherein said stimulator is coupled to one or more electrodes, and wherein said stimulus comprises a stimulation current delivered via said electrodes.

### Claim 24 (depends on 1)

The method of claim 1, wherein said stimulus comprises one or more drugs delivered to said stimulation site.

### Claim 25 (depends on 1)

The method of claim 1, wherein said stimulus comprises a stimulation current delivered to said stimulation site and one or more drugs delivered to said stimulation site.

### Claim 26 (depends on 1)

The method of claim 1, wherein said stimulus is configured to decrease activity of said stimulation site to treat said psychotic disorder.

### Claim 27 (depends on 1)

The method of claim 1, wherein said stimulus is configured to increase activity of said stimulation site to treat said psychotic disorder.

### Claim 28 (depends on 1)

The method of claim 1, wherein said stimulator is at least partially disposed in a skull of said patient.

### Claim 29 (depends on 1)

The method of claim 1, wherein said at least one indicator comprises a discharge frequency of a neural population in said stimulation site.

### Claim 30 (depends on 1)

The method of claim 1, wherein said at least one indicator comprises a chemical level of said stimulation site.

### Claim 31 (depends on 1)

The method of claim 1, wherein said at least one indicator comprises a neurotransmitter level.

### Claim 32 (depends on 1)

The method of claim 1, wherein said at least one indicator comprises a hormone level.

### Claim 33 (depends on 1)

The method of claim 1, wherein said at least one indicator comprises a drug level within said patient.

### Claim 34 (depends on 1)

The method of claim 1, wherein said at least one indicator comprises a change in blood plasma.

### Claim 35 (depends on 1)

The method of claim 1, wherein said at least one indicator comprises a change in interstitial fluid.

### Claim 36 (depends on 1)

The method of claim 1, wherein said at least one indicator comprises a change in cerebrospinal fluid.

### Claim 37 (depends on 1)

The method of claim 1, wherein said at least one indicator comprises at least one of a dopamine level, an interleukin level, a cytokine level, a lymphokine level, a chemokine level, a growth factor level, an electrolyte level, and an enzyme level.
